TTSS2-deficient hha mutant of Salmonella Typhimurium exhibits significant systemic attenuation in immunocompromised hosts

Virulence

Volumn 5, Issue 2, 2014, Pages 311-320

  Vishwakarma, Vikalp ^a   Pati, Niladri Bhusan ^a   Ray, Shilpa ^a   Das, Susmita ^a   Suar, Mrutyunjay ^a  

^a KIIT UNIVERSITY   (India)

Author keywords

C57BL 6; hha; Immunocompromised host; Inflammation; Salmonella Typhimurium

Indexed keywords

HEMOLYSIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANTIBODY RESPONSE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; FLOW CYTOMETRY; GENE MUTATION; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; NONHUMAN; PATHOGENICITY ISLAND; PLASMID; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; TYPE III SECRETION SYSTEM; TYPHLITIS; VACCINATION;

C57BL/6; HHA; IMMUNOCOMPROMISED HOST; INFLAMMATION; SALMONELLATYPHIMURIUM;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL SECRETION SYSTEMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GASTROINTESTINAL TRACT; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SURVIVAL ANALYSIS; VIRULENCE;

EID: 84897882190     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.27605     Document Type: Article

References (49)

1. DuPont HL. The growing threat of foodborne bacterial enteropathogens of animal origin. Clin Infect Dis 2007; 45:1353-61; PMID:17968835; http://dx.doi.org/10.1086/522662
2. Thorns CJ. Bacterial food-borne zoonoses. Rev Sci Tech 2000; 19:226-39; PMID:11189717
3. Hedberg C. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5:840-2; PMID:10603229; http://dx.doi.org/10.3201/ eid0506.990624
4. Haraga A, Ohlson MB, Miller SI. Salmonellae interplay with host cells. Nat Rev Microbiol 2008; 6:53-66; PMID:18026123; http://dx.doi. org/10.1038/nrmicro1788
5. Altier C. Genetic and environmental control of salmonella invasion. J Microbiol 2005; 43:85-92; PMID:15765061
6. Suar M, Jantsch J, Hapfelmeier S, Kremer M, Stallmach T, Barrow PA, Hardt WD. Virulence of broad-and narrow-host-range Salmonella enterica serovars in the streptomycin-pretreated mouse model. Infect Immun 2006; 74:632-44; PMID:16369020; http://dx.doi.org/10.1128/IAI.74.1.632-644.2006
7. Coburn B, Grassl GA, Finlay BB. Salmonella, the host and disease: a brief review. Immunol Cell Biol 2007; 85:112-8; PMID:17146467; http://dx.doi. org/10.1038/sj.icb.7100007
8. Santos RL, Zhang S, Tsolis RM, Kingsley RA, Adams LG, Bäumler AJ. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect 2001; 3:1335-44; PMID:11755423; http:// dx.doi.org/10.1016/S1286-4579(01)01495-2
9. Barthel M, Hapfelmeier S, Quintanilla-Martínez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Rüssmann H, Hardt WD. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 2003; 71:2839-58; PMID:12704158; http://dx.doi. org/10.1128/IAI.71.5.2839-2858.2003
10. Waterman SR, Holden DW. Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cell Microbiol 2003; 5:501-11; PMID:12864810; http://dx.doi. org/10.1046/j.1462-5822.2003.00294.x
11. Galán JE. Salmonella interactions with host cells: type III secretion at work. Annu Rev Cell Dev Biol 2001; 17:53-86; PMID:11687484; http://dx.doi. org/10.1146/annurev.cellbio.17.1.53
12. Clark MA, Jepson MA, Simmons NL, Hirst BH. Preferential interaction of Salmonella typhimurium with mouse Peyer's patch M cells. Res Microbiol 1994; 145:543-52; PMID:7855440; http://dx.doi. org/10.1016/0923-2508(94)90031-0
13. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 1994; 180:15-23; PMID:8006579; http://dx.doi. org/10.1084/jem.180.1.15
14. Darwin KH, Miller VL. Molecular basis of the interaction of Salmonella with the intestinal mucosa. Clin Microbiol Rev 1999; 12:405-28; PMID:10398673
15. Hernandez LD, Hueffer K, Wenk MR, Galán JE. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 2004; 304:1805-7; PMID:15205533; http://dx.doi. org/10.1126/science.1098188
16. Galán JE, Curtiss R 3rd. Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci U S A 1989; 86:6383-7; PMID:2548211; http://dx.doi.org/10.1073/ pnas.86.16.6383
17. Lostroh CP, Lee CA. The Salmonella pathogenicity island-1 type III secretion system. Microbes Infect 2001; 3:1281-91; PMID:11755416; http://dx.doi. org/10.1016/S1286-4579(01)01488-5
18. Olekhnovich IN, Kadner RJ. DNA-binding activities of the HilC and HilD virulence regulatory proteins of Salmonella enterica serovar Typhimurium. J Bacteriol 2002; 184:4148-60; PMID:12107132; http://dx.doi. org/10.1128/JB.184.15.4148-4160.2002
19. Nieto JM, Carmona M, Bolland S, Jubete Y, de la Cruz F, Juárez A. The hha gene modulates haemolysin expression in Escherichia coli. Mol Microbiol 1991; 5:1285-93; PMID:1956303; http://dx.doi. org/10.1111/j.1365-2958.1991.tb01902.x
20. Fahlen TF, Wilson RL, Boddicker JD, Jones BD. Hha is a negative modulator of transcription of hilA, the Salmonella enterica serovar Typhimurium invasion gene transcriptional activator. J Bacteriol 2001; 183:6620-9; PMID:11673432; http://dx.doi. org/10.1128/JB.183.22.6620-6629.2001
21. Periaswamy B, Maier L, Vishwakarma V, Slack E, Kremer M, Andrews-Polymenis HL, McClelland M, Grant AJ, Suar M, Hardt WD. Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice. PLoS One 2012; 7:e45433; PMID:23029007; http://dx.doi. org/10.1371/journal.pone.0045433
22. Vishwakarma V, Pati NB, Chandel HS, Sahoo SS, Saha B, Suar M. Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice. PLoS One 2012; 7:e52043; PMID:23284865; http://dx.doi. org/10.1371/journal.pone.0052043
23. Endt K, Maier L, Käppeli R, Barthel M, Misselwitz B, Kremer M, Hardt WD. Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not. Antimicrob Agents Chemother 2012; 56:2295-304; PMID:22354292; http://dx.doi.org/10.1128/AAC.05819-11
24. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, Benecke A, Van Maele L, Sirard JC, Mueller AJ, Heikenwalder M, et al. The microbiota mediates pathogen clearance from the gut lumen after nontyphoidal Salmonella diarrhea. PLoS Pathog 2010; 6:e1001097; PMID:20844578; http://dx.doi. org/10.1371/journal.ppat.1001097
25. Mandomando I, Macete E, Sigaúque B, Morais L, Quintó L, Sacarlal J, Espasa M, Vallès X, Bassat Q, Aide P, et al. Invasive non-typhoidal Salmonella in Mozambican children. Trop Med Int Health 2009; 14:1467-74; PMID:19793081; http://dx.doi. org/10.1111/j.1365-3156.2009.02399.x
26. Pulickal AS, Pollard AJ. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype? Expert Rev Vaccines 2007; 6:293-5; PMID:17542742; http://dx.doi. org/10.1586/14760584.6.3.293
27. Chuttani CS, Prakash K, Vergese A, Gupta P, Chawla RK, Grover V, Agarwal DS. Ineffectiveness of an oral killed typhoid vaccine in a field trial. Bull World Health Organ 1973; 48:754-5; PMID:4594320
28. Levine MM, Herrington D, Murphy JR, Morris JG, Losonsky G, Tall B, Lindberg AA, Svenson S, Baqar S, Edwards MF, et al. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest 1987; 79:888-902; PMID:3818953; http://dx.doi.org/10.1172/ JCI112899
29. Murphy JR, Grez L, Schlesinger L, Ferreccio C, Baqar S, Muñoz C, Wasserman SS, Losonsky G, Olson JG, Levine MM. Immunogenicity of Salmonella typhi Ty21a vaccine for young children. Infect Immun 1991; 59:4291-3; PMID:1937790
30. Black RE, Levine MM, Ferreccio C, Clements ML, Lanata C, Rooney J, Germanier R; Chilean Typhoid Committee. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in entericcoated capsules in a controlled field trial. Vaccine 1990; 8:81-4; PMID:2180234; http://dx.doi. org/10.1016/0264-410X(90)90183-M
31. Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, Kossaczka Z, Bryla DA, Shiloach J, Robbins JB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001; 344:1263-9; PMID:11320385; http://dx.doi.org/10.1056/NEJM200104263441701
32. Grant AJ, Morgan FJ, McKinley TJ, Foster GL, Maskell DJ, Mastroeni P. Attenuated Salmonella Typhimurium lacking the pathogenicity island-2 type 3 secretion system grow to high bacterial numbers inside phagocytes in mice. PLoS Pathog 2012; 8:e1003070; PMID:23236281; http://dx.doi. org/10.1371/journal.ppat.1003070
33. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013; 41:D808-15; PMID:23203871; http://dx.doi.org/10.1093/nar/ gks1094
34. Olekhnovich IN, Kadner RJ. Role of nucleoidassociated proteins Hha and H-NS in expression of Salmonella enterica activators HilD, HilC, and RtsA required for cell invasion. J Bacteriol 2007; 189:6882-90; PMID:17675384; http://dx.doi.org/10.1128/ JB.00905-07
35. Wiedemann A, Rosselin M, Mijouin L, Bottreau E, Velge P. Involvement of c-Src tyrosine kinase upstream of class I phosphatidylinositol (PI) 3-kinases in Salmonella Enteritidis Rck proteinmediated invasion. J Biol Chem 2012; 287:31148-54; PMID:22810232; http://dx.doi.org/10.1074/jbc. M112.392134
36. Mijouin L, Rosselin M, Bottreau E, Pizarro-Cerda J, Cossart P, Velge P, Wiedemann A. Salmonella enteritidis Rck-mediated invasion requires activation of Rac1, which is dependent on the class I PI 3-kinases-Akt signaling pathway. FASEB J 2012; 26:1569-81; PMID:22210834; http://dx.doi. org/10.1096/fj.11-189647
37. Johanns TM, Ertelt JM, Rowe JH, Way SS. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 2010; 6:e1001043; PMID:20714351; http://dx.doi. org/10.1371/journal.ppat.1001043
38. Yrlid U, Svensson M, Håkansson A, Chambers BJ, Ljunggren HG, Wick MJ. In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect Immun 2001; 69:5726-35; PMID:11500449; http://dx.doi. org/10.1128/IAI.69.9.5726-5735.2001
39. McSorley SJ, Asch S, Costalonga M, Reinhardt RL, Jenkins MK. Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 2002; 16:365-77; PMID:11911822; http://dx.doi.org/10.1016/ S1074-7613(02)00289-3
40. Gautreaux MD, Deitch EA, Berg RD. T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract. Infect Immun 1994; 62:2874-84; PMID:7911786
41. Apter FM, Lencer WI, Finkelstein RA, Mekalanos JJ, Neutra MR. Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro. Infect Immun 1993; 61:5271-8; PMID:7693598
42. Hutchings AB, Helander A, Silvey KJ, Chandran K, Lucas WT, Nibert ML, Neutra MR. Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches. J Virol 2004; 78:947-57; PMID:14694126; http://dx.doi. org/10.1128/JVI.78.2.947-957.2004
43. Brandtzaeg P. Role of secretory antibodies in the defence against infections. Int J Med Microbiol 2003; 293:3-15; PMID:12755363; http://dx.doi. org/10.1078/1438-4221-00241
44. Mantis NJ, Forbes SJ. Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest 2010; 39:383-406; PMID:20450284; http:// dx.doi.org/10.3109/08820131003622635
45. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000; 97:6640-5; PMID:10829079; http://dx.doi. org/10.1073/pnas.120163297
46. Lesic B, Rahme LG. Use of the lambda Red recombinase system to rapidly generate mutants in Pseudomonas aeruginosa. BMC Mol Biol 2008; 9:20; PMID:18248677; http://dx.doi. org/10.1186/1471-2199-9-20
47. Hapfelmeier S, Stecher B, Barthel M, Kremer M, Müller AJ, Heikenwalder M, Stallmach T, Hensel M, Pfeffer K, Akira S, et al. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol 2005; 174:1675-85; PMID:15661931
48. Suar M, Periaswamy B, Songhet P, Misselwitz B, Müller A, Käppeli R, Kremer M, Heikenwalder M, Hardt WD. Accelerated type III secretion system 2-dependent enteropathogenesis by a Salmonella enterica serovar enteritidis PT4/6 strain. Infect Immun 2009; 77:3569-77; PMID:19528213; http:// dx.doi.org/10.1128/IAI.00511-09
49. Vishwakarma V, Periaswamy B, Bhusan Pati N, Slack E, Hardt WD, Suar M. A novel phage element of Salmonella enterica serovar Enteritidis P125109 contributes to accelerated type III secretion system 2-dependent early inflammation kinetics in a mouse colitis model. Infect Immun 2012; 80:3236-46; PMID:22753379; http://dx.doi.org/10.1128/ IAI.00180-12